Erratum: IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer (Cancer Gene Therapy (2001) 14, (819-827) DOI: 10.1038/sj.cgt.7701069)

H. Wang; G. Yang; T. L. Timme; T. Fujita; K. Naruishi; A. Frolov; M. K. Brenner; D. Kadmon; T. C. Thompson

doi:10.1038/sj.cgt.7701084

Erratum: IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer (Cancer Gene Therapy (2001) 14, (819-827) DOI: 10.1038/sj.cgt.7701069)

H. Wang, G. Yang, T. L. Timme, T. Fujita, K. Naruishi, A. Frolov, M. K. Brenner, D. Kadmon, T. C. Thompson

Houston Methodist

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	873-874
Number of pages	2
Journal	Cancer Gene Therapy
Volume	14
Issue number	10
DOIs	https://doi.org/10.1038/sj.cgt.7701084
State	Published - Oct 2007

ASJC Scopus subject areas

Molecular Medicine
Molecular Biology
Cancer Research

Access to Document

10.1038/sj.cgt.7701084

Cite this

Wang, H., Yang, G., Timme, T. L., Fujita, T., Naruishi, K., Frolov, A., Brenner, M. K., Kadmon, D., & Thompson, T. C. (2007). Erratum: IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer (Cancer Gene Therapy (2001) 14, (819-827) DOI: 10.1038/sj.cgt.7701069). Cancer Gene Therapy, 14(10), 873-874. https://doi.org/10.1038/sj.cgt.7701084

Erratum: IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer (Cancer Gene Therapy (2001) 14, (819-827) DOI: 10.1038/sj.cgt.7701069). / Wang, H.; Yang, G.; Timme, T. L. et al.
In: Cancer Gene Therapy, Vol. 14, No. 10, 10.2007, p. 873-874.

Research output: Contribution to journal › Comment/debate › peer-review

Wang, H, Yang, G, Timme, TL, Fujita, T, Naruishi, K, Frolov, A, Brenner, MK, Kadmon, D & Thompson, TC 2007, 'Erratum: IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer (Cancer Gene Therapy (2001) 14, (819-827) DOI: 10.1038/sj.cgt.7701069)', Cancer Gene Therapy, vol. 14, no. 10, pp. 873-874. https://doi.org/10.1038/sj.cgt.7701084

@article{c282da031fe641daa7f550f8c5552470,

title = "Erratum: IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer (Cancer Gene Therapy (2001) 14, (819-827) DOI: 10.1038/sj.cgt.7701069)",

author = "H. Wang and G. Yang and Timme, \{T. L.\} and T. Fujita and K. Naruishi and A. Frolov and Brenner, \{M. K.\} and D. Kadmon and Thompson, \{T. C.\}",

year = "2007",

month = oct,

doi = "10.1038/sj.cgt.7701084",

language = "English (US)",

volume = "14",

pages = "873--874",

journal = "Cancer Gene Therapy",

issn = "0929-1903",

publisher = "Springer Nature",

number = "10",

}

TY - JOUR

T1 - Erratum

T2 - IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer (Cancer Gene Therapy (2001) 14, (819-827) DOI: 10.1038/sj.cgt.7701069)

AU - Wang, H.

AU - Yang, G.

AU - Timme, T. L.

AU - Fujita, T.

AU - Naruishi, K.

AU - Frolov, A.

AU - Brenner, M. K.

AU - Kadmon, D.

AU - Thompson, T. C.

PY - 2007/10

Y1 - 2007/10

UR - https://www.scopus.com/pages/publications/34548636660

UR - https://www.scopus.com/inward/citedby.url?scp=34548636660&partnerID=8YFLogxK

U2 - 10.1038/sj.cgt.7701084

DO - 10.1038/sj.cgt.7701084

M3 - Comment/debate

AN - SCOPUS:34548636660

SN - 0929-1903

VL - 14

SP - 873

EP - 874

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

IS - 10

ER -

Erratum: IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer (Cancer Gene Therapy (2001) 14, (819-827) DOI: 10.1038/sj.cgt.7701069)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this